➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Johnson and Johnson
Merck
Harvard Business School
Dow

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Anthrax vaccine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Anthrax vaccine?

Anthrax vaccine is an investigational drug.

There have been 14 clinical trials for Anthrax vaccine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Anthrax, Cystitis, and Cystic Fibrosis. The leading clinical trial sponsors are Department of Health and Human Services, Bayer, and National Institute of Allergy and Infectious Diseases (NIAID).

There are thirteen US patents protecting this investigational drug and seventy-five international patents.

Recent Clinical Trials for Anthrax vaccine
TitleSponsorPhase
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyBiomedical Advanced Research and Development AuthorityPhase 2
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyEmergent Product Development Gaithersburg, Inc.Phase 2
BARDA Securing Anthrax Immunity For the ElderlyRho, Inc.Phase 2

See all Anthrax vaccine clinical trials

Clinical Trial Summary for Anthrax vaccine

Top disease conditions for Anthrax vaccine
Top clinical trial sponsors for Anthrax vaccine

See all Anthrax vaccine clinical trials

US Patents for Anthrax vaccine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Anthrax vaccine   Try Before You Buy Albumin derivatives and variants ALBUMEDIX LTD (Nottingham, GB)   Try Before You Buy
Anthrax vaccine   Try Before You Buy Flagellin-based agents and uses including effective vaccination GENOME PROTECTION, INC. (Buffalo, NY)   Try Before You Buy
Anthrax vaccine   Try Before You Buy Temperature stable vaccine formulations Emergent Product Development Gaithersburg Inc. (Gaithersburg, MD)   Try Before You Buy
Anthrax vaccine   Try Before You Buy Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same EYEGENE INC. (Seoul, KR)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Anthrax vaccine

Drugname Country Document Number Estimated Expiration Related US Patent
Anthrax vaccine China CN102939304 2030-04-09   Try Before You Buy
Anthrax vaccine China CN106977608 2030-04-09   Try Before You Buy
Anthrax vaccine European Patent Office EP2556087 2030-04-09   Try Before You Buy
Anthrax vaccine Japan JP2013523145 2030-04-09   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.